| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9334123 | Progresos de Obstetricia y Ginecología | 2005 | 8 Pages |
Abstract
More precise methodology is required for the systematic application of nasal bone assessment as a marker of trisomy 21. Nasal bone should be considered together with maternal age, nuchal translucency and blood test to increase the accuracy of screening.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
F. Sellers, J.M. Lozano, N. Ariza, T. MartÃn, M. Roca, V. Gil, R. Bernabeu,